S21B - Better Skincare Is at Your Fingertips. Breakthrough Dermatopical Innovation Is Improving Outcomes & Increasing Compliance I

Monday, September 6, 2021

10:00 AM – 10:50 AM US PDT

Location: Oceanside D, Level 2

CE: 1 CE Credit(s)

Sponsored By

Presenter(s)

Melissa Hall, DVM, DACVD

Associate
Animal Dermatology Clinic
Tustin, CA, United States

Moderator(s)

Edward Koronowski, DVM

Veterinary Service Mgr.
CEVA ANIMAL HEALTH
Lenexa, Kansas, United States

Presenter(s)

Michael Rossi, DVM, MNS< DACVD

Director of Clinical Studies
Coastal Veterinary Dermatology & Ear Clinic
Houston, TX, United States

We will present an overview of user needs for topical therapy and expectations in practice. Case studies of atopic dermatitis and seborrheic disorders treated with DOUXO S3 will be discussed. Part 1 of 2.

Learning Objectives:

Understand the users’ expectations in terms of topical therapy and how these were key in the development of the new Dermatopical DOUXO® S3 whose patented protocol is expected to improve client compliance
Learn about the efficacy of new DOUXO® S3 CALM that has been proven to help repair the skin barrier in canine atopic dermatitis.
Learn about the efficacy of new DOUXO® S3 SEB that has been proven to help repair the skin barrier in seborrheic disorders.